We are living in the age of big data. Drug development companies are swimming in information that can inform their processes and assist them in bringing a treatment to market; but this information is no longer solely generated through clinical trials.​As the cost of healthcare continues to rise and companies face pricing pressures, there comes a growing need to demonstrate t...

More than a year has passed since Covid-19 first hit the headlines, and across the world nine vaccines have received authorisation for use in various geographies. But for firms involved in researching and trialling treatments for the virus, it isn’t job-done just yet. ​When it was announced that some of the major frontrunners in the race to develop a Covid-19 had succeeded i...